반응식
[C:1]([O:5][C:6]([N:8]1[CH:13]2[CH2:14][CH2:15][CH:9]1[CH2:10][NH:11][CH2:12]2)=[O:7])([CH3:4])([CH3:3])[CH3:2].Cl[C:17]1[CH:26]=[CH:25][C:24]2[C:19](=[CH:20][CH:21]=[C:22]([N+:27]([O-:29])=[O:28])[CH:23]=2)[N:18]=1>>[C:1]([O:5][C:6]([N:8]1[CH:9]2[CH2:15][CH2:14][CH:13]1[CH2:12][N:11]([C:17]1[CH:26]=[CH:25][C:24]3[C:19](=[CH:20][CH:21]=[C:22]([N+:27]([O-:29])=[O:28])[CH:23]=3)[N:18]=1)[CH2:10]2)=[O:7])([CH3:4])([CH3:2])[CH3:3]참가 물질
3
실험 절차
Was prepared according to method A from 3,8-diaza-bicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester and 2-chloro-6-nitroquinoline. Decomp.
후처리
- customWas prepared
출처 및 근거
- ORD 기록
- ord-01983eb2a86b47139e8005b0b4b4af73
- 출처 데이터셋
- uspto-grants-2010_04
- 특허 번호
- US07704991B2
연결된 노트
불러오는 중…